This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ of other and unspecified parts of face
CD2_INSITU_MELANOMA_FACE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of other and unspecified parts of face
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of other and unspecified parts of face
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 360 | 182 | 178 |
| Unadjusted period prevalence (%) | 0.07 | 0.06 | 0.08 |
| Median age at first event (years) | 72.56 | 71.12 | 74.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 316
- Matched controls
- 3158
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
+∞
323.0
305
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
213.5
259.8
251
56
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
552.9
87.7
83
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
17.8
85.7
147
147
ZZR00
NOMESCO Finland
Flap of skin
337.6
79.4
77
*
L57.0
ICD-10 Finland
Actinic keratosis
14.0
74.1
142
174
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
+∞
67.1
62
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
57.0
53
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
21.9
56.7
85
52
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
47.1
44
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
41.6
39
*
TQW99
NOMESCO Finland
Other minor procedure on skin
13.6
40.6
73
68
D03.30
ICD-10 Finland
Melanoma in situ on the lip
+∞
40.5
38
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
39.4
37
*
S18
ICPC
Laceration/cut
4.9
37.7
216
973
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.4
37.1
114
257
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
22.1
33.5
49
26
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
32.9
31
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
31.8
30
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.2
31.7
62
67
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
52.1
31.3
37
8
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
31.2
31.1
41
15
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
29.6
28
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
15.0
29.1
49
38
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
30.5
25.0
33
12
ZZA50
NOMESCO Finland
Full thickness skin graft
+∞
23.2
22
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
22.9
23.1
33
16
D06BB10
ATC
imiquimod; topical
9.1
23.1
50
64
SPAT1153
SPAT
Removal of sutures
3.4
22.6
158
720
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
123.6
21.9
23
*
ZXC50
NOMESCO Finland
Cryotherapy
14.4
21.3
36
28
DHB00
NOMESCO Finland
Excision of lesion of external nose
82.5
21.0
23
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
10.5
20.3
40
43
115
Kela drug reimbursment
Breast cancer
+∞
20.0
19
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
18.9
18
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
14.1
18.9
32
25
S77
ICPC
Malignant neoplasm of skin
106.4
18.8
20
*
WX110
NOMESCO Finland
Local anesthesy
3.0
18.2
226
1436
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
70.8
17.9
20
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
17.6
16.9
26
16
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
16.8
16
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
16.8
16
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
179.0
16.7
17
*
L02BG04
ATC
letrozole; oral
179.0
16.7
17
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
179.0
16.7
17
*
ZXC20
NOMESCO Finland
Use of chemical agents
12.6
16.4
29
25
WF002
NOMESCO Finland
Radical radiotherapy
167.9
15.6
16
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.3
15.3
87
322
Z2221
NOMESCO Finland
Medical doctor
2.9
15.2
120
555
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
14.7
14
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
14.7
14
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
14.7
14
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
14.7
14
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
14.2
103
449
XX3DW
NOMESCO Finland
Time consuming IT work
6.5
14.1
37
63
HAB40
NOMESCO Finland
Wedge excision of mammary gland
78.6
13.7
15
*
130
Kela drug reimbursment
Malignant tumour
+∞
13.6
13
*
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
9.7
13.5
27
30
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
16.3
12.8
20
13
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
12.6
12
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
12.6
12
*
116
Kela drug reimbursment
Prostate cancer
+∞
12.6
12
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
12.6
12
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
12.6
12
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
135.1
12.5
13
*
D03.5
ICD-10 Finland
Melanoma in situ of trunk
135.1
12.5
13
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
9.9
12.2
24
26
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
8.9
12.0
25
30
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
17.2
11.8
18
11
S82
ICPC
Naevus/mole
3.5
11.8
58
190
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
67.5
11.7
13
*
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
+∞
11.5
11
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
11.5
11
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
11.5
11
*
ZZA00
NOMESCO Finland
Split skin graft
7.8
11.5
26
36
HA1AA
NOMESCO Finland
X-ray mammography
9.4
11.5
23
26
I78.1
ICD-10 Finland
Naevus, non-neoplastic
11.2
11.4
21
20
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
45.0
11.0
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
10.5
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.5
10
*
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
+∞
10.5
10
*
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
24.3
10.3
14
6
H02AB02
ATC
dexamethasone; systemic
13.7
10.3
17
13
ZQZ00
NOMESCO Finland
Treatment of several skin areas
41.5
10.0
12
*
J01DB01
ATC
cefalexin; oral
2.5
9.9
260
2053
WX002
NOMESCO Finland
Sedation and analgesia
2.4
9.8
93
460
ZXC15
NOMESCO Finland
Use of photodynamic technique
14.0
9.8
16
12
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
18.2
9.5
14
8
ZXE00
NOMESCO Finland
One hour or less
2.2
9.5
136
816
L02AE02
ATC
leuprorelin; implant, parenteral
103.0
9.5
10
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
22.5
9.4
13
6
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
+∞
9.4
9
*
L02BB03
ATC
bicalutamide; oral
+∞
9.4
9
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
9.4
9
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
9.4
9
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
11.2
9.4
17
16
S29
ICPC
Skin symptom/complaint other
2.6
9.2
72
319
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
37.8
9.1
11
*
JN4AD
NOMESCO Finland
Body CT examination
6.0
8.6
23
41
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
92.4
8.5
9
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.4
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
Y77
ICPC
Malignant neoplasm prostate
46.1
7.7
9
*
S21
ICPC
Skin texture symptom/complaint
2.7
7.7
54
223
DAB00
NOMESCO Finland
Excision of lesion of auricle
18.9
7.7
11
6
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
18.9
7.7
11
6
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
7.6
125
775
R4110
NOMESCO Finland
Physiotherapy
2.1
7.5
95
528
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
13.8
7.4
12
9
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
7.4
135
870
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
+∞
7.3
7
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
7.3
7
*
8742/2-C44.3
ICD-O-3
Lentigo maligna of skin of other and unspecified parts of face
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
7.3
7
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
7.2
52
218
D22
ICD-10 Finland
Melanocytic naevi
6.3
7.2
18
30
WX402
NOMESCO Finland
General anaesthesia
2.7
7.1
48
195
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
7.1
87
476
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
6.9
24
59
A98
ICPC
Health maint/preventive medicine
3.0
6.8
296
2631
A04AA02
ATC
granisetron; systemic, transdermal
40.9
6.8
8
*
JN4BD
NOMESCO Finland
Extensive body CT
3.6
6.7
29
86
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
6.7
161
1131
S26
ICPC
Fear of cancer of skin
12.6
6.6
11
9
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
7.1
6.6
15
22
Z3231
NOMESCO Finland
Registered nurse
2.0
6.6
97
570
A04AA01
ATC
ondansetron; systemic, rectal
5.4
6.4
18
35
TQW40
NOMESCO Finland
Remowal of suture of skin
3.2
6.4
32
107
D06BX02
ATC
ingenol mebutate; topical
7.3
6.3
14
20
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
7.3
6.3
14
20
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
6.3
6
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
6.3
6
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
6.3
6
*
8742/3-C44.3
ICD-O-3
Lentigo maligna melanoma of skin of other and unspecified parts of face
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
6.3
6
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
6.3
6
*
XQ848
NOMESCO Finland
Dermatological photography
5.6
6.2
17
32
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
6.2
82
461
H01.0
ICD-10 Finland
Blepharitis
4.2
6.2
22
55
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
8.9
6.1
12
14
F16
ICPC
Eyelid symptom/complaint
3.9
6.0
23
62
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
173
195
16.15
153.70
1.8
1.1
—
—
—
0
0
(4035726)
95
69
18.35
107.32
1.4
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
282
853
11.64
104.62
4.5
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
62
116
6.25
32.93
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
336
2669
4.88
15.09
20.1
13.7
ml/min/173m2
70.8
71.4
0.19
280
2137
(3033658) Prothrombin time (PT) actual/Normal
131
676
2.47
14.35
4.7
3.4
%
81.9
84.0
0.40
126
657
(3044640) Blood type and Crossmatch panel - Blood
149
837
2.33
13.28
2.4
2.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
351
3100
6.29
11.93
30.8
21.6
e9/l
6.7
6.8
0.76
339
2979
(42870588) Differential panel, method unspecified - Blood
155
917
2.21
11.89
6.2
5.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
191
1230
2.18
11.80
6.5
5.1
%
0.7
0.7
0.01
162
1133
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
213
1433
2.19
11.75
7.6
5.0
mmol/l
1.2
1.2
0.15
192
1263
(36304419) Bacteria [Presence] in Urine
141
822
2.18
11.05
4.0
3.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
193
1272
2.12
10.96
6.6
5.3
%
9.1
8.8
0.86
165
1175
(3006504) Eosinophils/100 leukocytes in Blood
192
1264
2.11
10.92
6.5
5.1
%
2.6
3.0
1.09
163
1165
(3002030) Lymphocytes/100 leukocytes in Blood
193
1289
2.07
10.38
6.6
5.3
%
27.1
26.1
0.55
165
1181
(3018010) Neutrophils/100 leukocytes in Blood
192
1281
2.07
10.35
6.4
5.1
%
58.3
58.5
0.07
166
1187
(3006315) Basophils [#/volume] in Blood
200
1362
2.05
10.11
6.5
4.8
e9/l
0.0
0.0
0.92
155
1179
(3019198) Lymphocytes [#/volume] in Blood
202
1381
2.05
10.09
6.4
4.9
e9/l
1.7
1.8
0.56
158
1205
(3013650) Neutrophils [#/volume] in Blood by Automated count
216
1515
2.06
10.03
9.1
5.7
e9/l
3.9
4.5
3.95
174
1322
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
47
172
2.99
9.90
3.7
1.4
ug/l
4.7
4.6
0.01
35
136
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
115
643
2.16
9.83
2.4
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
142
861
2.07
9.80
4.0
3.0
e6/l
0.5
0.5
0.00
118
650
(3013115) Eosinophils [#/volume] in Blood
204
1412
2.03
9.71
6.7
5.0
e9/l
0.2
0.2
1.44
159
1232
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
186
1246
2.02
9.71
4.6
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
334
2829
3.50
9.63
19.5
14.5
mg/l
24.0
25.1
0.23
264
2234
(3018095) Leukocytes [#/volume] in Urine
166
1074
2.01
9.50
4.8
3.7
e6/l
86.1
114.1
0.22
126
778
(3001604) Monocytes [#/volume] in Blood
197
1355
2.00
9.45
6.6
4.8
e9/l
0.6
0.6
0.81
152
1164
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
220
1580
2.01
9.25
7.8
5.4
mmol/l
1.2
1.2
0.09
183
1347
(3002582) Erythrocytes [#/volume] in Urine
148
931
2.00
9.07
4.0
3.1
e6/l
121.5
134.9
0.06
123
720
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
108
3.37
9.03
3.2
1.2
g/l
1.3
0.2
0.78
26
92
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
281
2219
2.21
8.97
8.5
5.2
u/l
80.1
77.5
0.31
257
2028
(3007461) Platelets [#/volume] in Blood
350
3098
5.67
8.54
31.0
21.6
e9/l
238.6
240.7
0.23
338
2991
(3024731) MCV [Entitic volume]
350
3098
5.67
8.54
30.7
21.5
fl
91.6
91.7
0.08
341
3024
(3026361) Erythrocytes [#/volume] in Blood
350
3099
5.66
8.51
30.8
21.6
e12/l
4.4
4.4
0.12
337
2977
(3035941) MCH [Entitic mass]
350
3099
5.66
8.51
30.7
21.5
pg
30.4
30.4
0.00
341
3025
(3000963) Hemoglobin [Mass/volume] in Blood
350
3099
5.66
8.51
31.0
21.7
g/l
132.5
133.6
0.64
341
3024
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
91
494
2.13
8.21
3.9
2.9
e6/l
2.2
2.4
0.09
52
274
(3009542) Hematocrit [Volume Fraction] of Blood
295
2406
2.25
8.21
23.8
16.6
%
39.4
38.5
0.90
189
1399
(3019550) Sodium [Moles/volume] in Serum or Plasma
346
3051
4.45
8.19
24.8
18.3
mmol/l
139.3
139.7
1.76
335
2950
(3021589) Normoblasts [#/volume] in Blood
178
1223
1.90
8.17
13.1
8.6
e9/l
0.0
0.0
1.55
138
1001
(40768793) Breast Pathology biopsy report
12
17
7.27
8.04
1.4
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
346
3057
4.39
8.04
25.6
18.4
mmol/l
4.0
4.0
1.39
336
2953
(3024561) Albumin [Mass/volume] in Serum or Plasma
190
1345
1.87
7.84
5.0
3.4
g/l
35.3
35.1
0.15
170
1239
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
164
1110
1.88
7.78
4.0
3.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
342
3015
3.69
7.64
13.3
9.5
u/l
22.9
23.5
0.37
325
2850
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
198
1431
1.85
7.54
6.1
3.7
umol/l
12.3
11.9
0.15
184
1330
(3037467) Urinalysis macro (dipstick) panel - Urine
259
2043
1.95
7.46
4.9
4.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
334
2916
3.01
7.38
19.4
14.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
141
923
1.87
7.32
7.0
3.2
ph
7.4
7.4
0.14
32
148
(3035637) Corticotropin [Mass/volume] in Plasma
12
19
6.50
7.29
1.1
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
126
797
1.89
7.27
1.7
1.6
mmol/l
1.3
1.3
0.30
98
650
(3020630) Protein [Mass/volume] in Serum or Plasma
58
277
2.30
7.11
2.9
1.6
g/l
65.0
67.0
0.92
51
242
(3034860) Kappa light chains.free [Mass/volume] in Serum
29
97
3.16
7.10
3.3
1.4
mg/l
60.2
44.3
0.40
22
76
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
100
592
1.95
7.00
3.9
2.8
ug/l
0.9
0.8
0.36
76
430
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
29
98
3.13
6.98
3.4
1.3
mg/l
55.8
31.4
0.99
22
78
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
315
2703
2.32
6.73
4.6
4.5
mmol/l
1.2
1.2
0.55
276
2384
(3026493) Urate [Moles/volume] in Serum or Plasma
122
782
1.85
6.65
2.6
2.6
umol/l
8449.8
11098.1
0.17
95
653
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
30
107
2.97
6.60
2.3
1.2
g/l
36.1
37.2
0.39
23
87
(3026782) Osmolality of Urine
103
628
1.90
6.55
2.7
2.7
mosm/kgh2o
556.9
535.0
0.55
90
523
(3049717) Cytology report of Urine Cyto stain
31
114
2.88
6.46
3.1
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
102
623
1.89
6.44
7.1
4.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
157
1094
1.77
6.44
6.3
4.2
ug/l
3.0
2.2
0.94
134
968
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
323
2814
2.44
6.43
5.4
5.0
mmol/l
1.5
1.5
0.80
286
2513
(3015377) Calcium [Moles/volume] in Serum or Plasma
151
1041
1.78
6.42
3.1
2.1
mmol/l
2.4
2.4
0.04
120
843
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
325
2840
2.48
6.41
5.4
5.0
mmol/l
4.4
4.4
0.02
290
2553
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
313
2694
2.24
6.38
5.6
4.9
mu/l
1.9
2.0
0.64
274
2377
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
331
2918
2.67
6.38
6.2
5.7
mmol/l
2.5
2.5
0.07
298
2623
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
235
2.31
6.35
2.1
2.1
u/l
27.5
32.1
0.92
41
193
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
128
2.74
6.24
2.3
1.3
g/l
3.1
3.0
0.12
24
98
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
91
541
1.91
6.21
3.8
2.7
e6/l
1.5
1.2
0.21
52
319
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
269
2210
1.86
6.08
4.3
3.9
pmol/l
15.1
15.2
0.10
222
1952
(3002385) Erythrocyte distribution width [Ratio]
270
2221
1.86
6.08
26.9
17.9
%
13.8
13.8
0.05
265
2158
(3000492) Spirometry study
44
200
2.37
6.02
1.7
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
319
2786
2.27
5.95
6.9
7.0
mmol/mol
40.0
41.3
1.80
289
2532
(3032080) INR in Blood by Coagulation assay
182
1346
1.71
5.88
11.5
10.8
inr
1.3
1.4
1.44
55
354
(40768795) Lymph node Pathology biopsy report
10
9
11.38
5.83
1.5
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
59
312
2.07
5.58
3.6
3.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
266
2205
1.79
5.51
4.8
4.3
mm/h
14.9
13.8
0.39
244
1977
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
326
2893
2.34
5.50
5.9
5.3
mmol/l
6.0
6.1
0.65
289
2562
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
131
2.58
5.46
2.3
1.2
g/l
10.5
10.6
0.01
24
110
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
55
286
2.09
5.44
3.2
2.3
umol/l
6.8
6.8
0.01
47
251
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
192
1464
1.67
5.35
2.1
2.1
pmol/l
94.5
93.0
0.15
94
730
(40768806) Pleura Pathology biopsy report
11
22
5.13
5.29
1.2
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
143
2.44
5.02
2.3
1.2
g/l
7.1
7.5
0.60
25
100
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
143
2.44
5.02
2.3
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
143
2.44
5.02
2.3
1.2
g/l
3.5
3.7
0.59
23
96
(40760888) Immunoglobulin light chains.free panel - Serum
20
67
3.10
4.91
4.1
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
45
226
2.13
4.86
4.0
3.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
100
663
1.70
4.62
2.5
2.4
e6/l
4.0
5.3
0.74
93
573
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
85
548
1.72
4.32
1.9
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
53
297
1.92
4.25
1.4
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
69
421
1.79
4.24
2.2
2.6
mmol/l
0.8
0.8
0.02
62
388
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
163
1242
1.57
4.23
2.1
2.3
nmol/l
81.6
79.8
0.35
134
1052
(3023368) Bacteria identified in Blood by Culture
121
862
1.61
4.17
5.3
3.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
58
340
1.84
4.05
1.8
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
200
1610
1.55
3.98
3.7
2.9
u/l
43.3
48.1
0.65
173
1448
(3013512) EKG study
139
1035
1.56
3.92
4.2
4.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
154
1179
1.54
3.81
3.6
2.7
ug/l
148.0
133.5
0.36
134
1062
(3004588) Protein electrophoresis panel - Serum or Plasma
44
241
1.94
3.77
3.5
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
35
3.51
3.65
1.2
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6
6
10.14
3.51
1.5
1.0
u/ml
13.7
17.0
—
6
6
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
93
648
1.59
3.44
3.6
2.2
mmol/l
2.4
2.4
0.04
80
552
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
10
7.11
3.38
1.4
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
119
880
1.53
3.37
5.0
4.1
%
22.4
24.9
0.93
51
456
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
32
3.51
3.36
1.4
1.2
u/ml
278.5
320.7
—
6
16
(40768800) Prostate Pathology biopsy report
8
15
5.43
3.21
1.3
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
216
1817
1.47
3.16
5.4
4.3
mmol/l
6.6
6.9
1.87
207
1692
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
159
1261
1.47
3.16
2.2
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
34
3.31
3.08
1.3
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
246
2129
1.49
3.07
5.1
4.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
121
913
1.49
3.07
1.6
1.5
nmol/l
19.8
21.1
0.44
99
766
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
134
1039
1.46
2.94
1.9
2.2
u/l
170.2
284.8
0.66
123
963
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
33
181
1.91
2.85
1.4
1.6
%
1.4
1.7
1.72
25
153
(3000991) Gas panel - Venous blood
43
257
1.76
2.83
10.3
6.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
219
1.82
2.82
1.9
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
43
2.85
2.67
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
31
172
1.88
2.60
2.0
2.9
e9/l
3.3
3.8
0.85
15
117
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
45
281
1.69
2.55
4.9
3.6
ng/l
98.1
86.1
0.46
40
243
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
65
448
1.55
2.48
1.3
1.3
iu/ml
24.1
45.3
0.94
15
150
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
12
5.06
2.41
2.0
1.5
nmol/l
13.4
4.5
—
6
12
(3047189) Immunofixation for 24 hour Urine
5
8
6.32
2.38
1.0
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
84
618
1.47
2.36
2.0
1.7
mg/l
1.3
1.3
0.11
68
483
(3003327) Ova and parasites identified in Stool by Light microscopy
15
65
2.36
2.35
1.4
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
146
1192
1.38
2.28
2.8
3.1
ng/l
2818.2
1644.8
0.53
124
1034
(3019150) Specific gravity of Urine by Refractometry
47
690
0.63
2.25
4.7
4.5
kg/l
1.0
1.0
—
9
118
(3019225) pH of Specimen
50
333
1.58
2.22
3.3
3.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
61
427
1.52
2.18
5.2
5.4
%
35.1
33.2
0.62
39
270
(3003694) ABO and Rh group [Type] in Blood
83
622
1.43
2.11
1.4
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
25
3.25
2.10
1.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
8
25
3.25
2.10
2.0
2.0
ug/l
2.0
2.4
—
8
19
(3002179) Metamyelocytes/100 leukocytes in Blood
31
185
1.74
2.09
2.9
3.8
%
0.6
0.3
—
7
35
(3012441) Differential panel - Pleural fluid
8
26
3.12
2.02
1.4
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
26
3.12
2.02
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
105
1.96
2.00
1.7
2.5
u/ml
0.3
0.4
—
6
60
(3023520) Reticulocytes [#/volume] in Blood
46
310
1.55
1.95
2.8
2.5
e9/l
63.9
68.1
0.43
32
252
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
11
4.59
1.94
1.0
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
64
466
1.45
1.89
2.6
1.3
g/l
2.8
2.7
0.07
32
255
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
34
2.69
1.87
1.7
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
46
2.44
1.87
1.0
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
130
1070
1.34
1.85
3.1
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
40
2.54
1.85
1.7
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
59
425
1.46
1.84
4.5
2.5
%
21.0
21.9
0.25
54
359
(3004789) Transferrin [Mass/volume] in Serum or Plasma
62
451
1.45
1.84
4.2
2.4
g/l
2.2
2.3
0.50
57
415
(3000494) Fungus identified in Specimen by Culture
49
340
1.51
1.83
1.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
131
1.81
1.82
1.5
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
35
2.61
1.81
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
35
226
1.61
1.79
2.1
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
189
1.64
1.69
3.1
3.8
%
0.0
2.4
—
6
37
(3027945) Reticulocytes/100 erythrocytes in Blood
57
415
1.44
1.69
2.7
2.1
%
1.6
1.8
1.11
47
372
(3045142) Bone marrow Pathology biopsy report
7
25
2.83
1.65
1.0
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
54
391
1.45
1.65
2.1
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
14
3.61
1.62
3.6
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
43
2.36
1.61
1.0
1.2
nmol/l
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
15
77
1.99
1.61
1.3
1.2
—
1.7
—
0
9
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
32
2.53
1.60
1.8
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
15
78
1.96
1.56
1.3
1.2
—
3.4
—
0
14
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
72
555
1.37
1.55
1.2
1.2
u/ml
0.6
1.5
1.27
16
141
(40768797) Stomach Pathology biopsy report
58
431
1.41
1.55
1.3
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
15
3.36
1.53
1.2
1.1
nmol/l
107.2
142.3
—
5
15
(3011397) Hemoglobin [Presence] in Urine by Test strip
88
702
1.34
1.52
3.9
4.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
27
2.62
1.52
2.0
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
51
2.19
1.52
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
165
1435
1.28
1.50
4.0
4.1
estimate
0.0
0.0
0.00
33
232
(3045424) Erythrocytes [Presence] in Urine
9
37
2.47
1.49
1.6
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
196
1.58
1.48
3.1
3.8
%
0.0
0.1
—
6
41
(3009508) Creatinine [Moles/volume] in Urine
130
1099
1.29
1.47
3.6
3.2
mmol/l
6.6
6.9
0.32
101
909
(3024928) Oxygen saturation in Venous blood
15
80
1.91
1.47
3.1
2.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
118
1.74
1.44
1.6
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
6
22
2.76
1.44
1.0
2.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
22
2.76
1.44
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
39
2.34
1.44
3.2
3.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
165
1443
1.26
1.41
5.6
5.7
estimate
0.0
0.0
0.00
35
226
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
67
1.98
1.40
1.2
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
29
2.44
1.40
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
60
2.03
1.39
1.5
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
89
1.83
1.39
1.5
1.5
g/l
1.2
1.1
0.21
16
84
(3000475) Leukocytes [#/volume] in Synovial fluid
15
82
1.87
1.37
1.7
1.5
e6/l
12338.5
20858.5
—
6
59
(3014271) Vancomycin [Susceptibility]
6
23
2.64
1.37
2.0
2.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
23
2.64
1.37
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
184
1.57
1.36
1.1
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
17
2.97
1.36
2.0
2.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
167
1468
1.26
1.35
4.1
4.1
estimate
0.0
0.0
0.00
34
225
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
42
2.17
1.34
1.0
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
391
1.39
1.31
2.1
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
128
1094
1.26
1.30
3.7
3.3
mg/l
607.3
212.1
0.30
76
680
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
69
1.92
1.30
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
64
499
1.34
1.29
4.1
2.4
umol/l
11.8
12.5
0.46
59
448
(40760892) CBC W Ordered Manual Differential panel - Blood
66
518
1.34
1.28
4.5
4.0
—
—
—
0
0
(4094501)
14
77
1.85
1.27
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
180
1.54
1.25
2.3
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
113
957
1.26
1.24
2.7
2.1
u/l
63.5
57.5
0.29
101
869
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
56
1.99
1.23
1.6
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
30
206
1.50
1.22
3.2
3.7
%
0.5
0.7
—
8
46
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
71
1.86
1.21
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
71
1.86
1.21
1.3
1.4
—
—
—
0
0
(3015736) pH of Urine
132
1145
1.24
1.16
3.6
3.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
154
1359
1.23
1.16
3.9
4.1
ng/l
38.8
68.0
0.64
120
1053
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
39
2.07
1.16
3.6
1.8
e9/l
3.3
4.9
—
8
39
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
18
111
1.65
1.14
1.5
1.6
—
182.5
—
0
8
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
51
1.99
1.12
2.5
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
8
41
1.97
1.09
4.0
2.4
%
60.6
60.8
—
8
41
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
2.2
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
274
0.64
1.05
4.2
3.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
92
775
1.25
1.05
1.9
1.8
nmol/l
1258.3
1160.8
0.30
57
579
(3020682) Albumin/Creatinine [Ratio] in Urine
133
1167
1.22
1.04
4.7
4.1
mg/mmol
5.7
7.7
0.42
72
728
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
60
1.86
1.04
1.3
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
22
2.29
1.03
1.0
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
109
0.45
1.02
5.6
4.7
mmol/l
0.9
1.3
—
5
103
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
123
1.58
1.02
1.5
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
37
276
1.38
1.00
1.6
1.9
ug/g
94.2
154.2
0.92
26
206
(1616796) Gas panel - Central venous blood
11
61
1.83
0.99
2.1
3.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
108
1.60
0.98
2.9
3.6
—
—
—
0
0
(4062490)
5
23
2.19
0.98
1.0
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
23
2.19
0.98
1.4
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
54
429
1.30
0.98
2.4
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
55
1.84
0.93
1.8
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
28
2.16
0.92
3.7
2.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
71
1.71
0.90
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
29
2.09
0.89
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
29
2.09
0.89
1.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
29
2.09
0.89
1.0
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
29
2.09
0.89
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
29
2.09
0.89
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
204
1.40
0.88
3.1
2.5
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
30
2.02
0.87
1.3
1.3
pmol/l
71.0
75.4
—
6
30
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
44
1.84
0.86
2.1
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
93
801
1.22
0.86
3.4
2.5
u/l
94.7
32.6
0.50
86
763
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
37
284
1.34
0.86
1.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
65
1.71
0.83
1.1
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
97
1.57
0.82
1.5
1.6
—
—
—
0
0
(4034850)
7
121
0.57
0.79
12.9
13.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
25
0.00
0.79
0.0
2.2
—
128.5
—
0
6
(3044242) Glucose [Moles/volume] in Arterial blood
0
27
0.00
0.77
0.0
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
34
1.78
0.76
1.3
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
53
1.72
0.76
1.2
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
116
1.49
0.75
1.2
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
98
861
1.19
0.74
2.3
2.3
mg/l
2.9
3.0
0.34
79
732
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
26
194
1.37
0.73
2.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
92
1.54
0.73
1.5
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.0
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
60
1.69
0.73
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
11
68
1.64
0.72
1.0
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
13
193
0.66
0.71
1.8
2.8
mmol/l
26.0
25.4
0.65
13
187
(3042631) Mycobacterium sp identified in Specimen
7
40
1.76
0.71
2.7
2.8
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.0
ng/l
563.4
524.3
—
5
15
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
27
1.86
0.68
1.2
1.4
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.0
ng/l
217.0
251.7
—
5
16
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
27
1.86
0.68
1.0
1.0
ng/l
33.8
35.9
—
5
16
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
28
360
0.76
0.68
2.0
2.5
ug/l
7.6
6.5
0.09
23
310
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
26
197
1.34
0.68
2.0
4.0
mmol/l
2.0
2.4
0.38
18
151
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
434
1.23
0.66
1.2
1.3
u/ml
31.0
17.2
—
10
141
(44790049)
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
(44790048)
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
28
1.80
0.66
1.2
1.5
—
—
—
0
0
(44790047)
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
(44806118)
5
28
1.80
0.66
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
71
1.57
0.63
1.7
2.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
49
1.65
0.62
1.9
1.4
—
—
—
0
0
(3020891) Body temperature
9
139
0.64
0.62
5.2
4.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
25
192
1.32
0.61
1.7
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
80
1.52
0.60
1.5
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
97
1.46
0.60
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
97
1.46
0.60
1.2
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
64
1.58
0.59
2.3
1.9
%
57.7
62.1
—
10
64
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
106
1.43
0.58
1.7
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
132
1.38
0.58
1.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
54
1.49
0.57
1.3
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
36
1.68
0.57
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
84
747
1.16
0.55
3.5
3.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
99
1.43
0.55
1.2
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
9
61
1.49
0.54
2.2
1.6
umol/l
26.3
35.9
—
9
52
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
61
1.49
0.54
1.1
1.1
—
26.9
—
0
5
(3052851) Hemolysis interference index of Serum or Plasma
13
91
1.44
0.53
4.3
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
152
1.33
0.53
2.6
4.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
40
1.51
0.52
1.7
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
201
0.74
0.50
2.5
4.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
45
1.57
0.49
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.1
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
47
1.50
0.48
1.0
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
46
397
1.18
0.44
8.6
5.2
mmol/l
104.0
104.2
0.09
46
384
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
168
1.27
0.41
10.8
7.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.5
—
1519.1
—
0
16
(3000764) Benzodiazepines [Presence] in Urine
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.4
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
86
787
1.12
0.38
3.5
3.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
36
1.39
0.38
1.6
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
39
340
1.16
0.35
1.5
1.3
titre
226.7
563.7
—
6
87
(3019832) Treponema pallidum Ab [Presence] in Serum
11
82
1.35
0.34
1.1
1.3
—
—
—
0
0
(4010399)
28
238
1.19
0.33
1.3
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
92
1.31
0.32
1.5
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
53
1.33
0.31
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
206
1.18
0.27
1.5
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
14
171
0.81
0.26
3.0
2.7
e6/l
0.5
0.2
0.30
14
166
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
75
697
1.10
0.26
3.9
4.2
ng/l
117.8
340.7
1.24
68
598
(3019060) Gas panel - Arterial blood
20
234
0.85
0.25
2.9
3.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
105
1107
0.93
0.24
4.4
4.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
39
1.29
0.23
1.0
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
5
40
1.25
0.22
1.4
1.7
%
90.7
90.4
—
5
40
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
229
1.15
0.22
2.7
2.0
ml/min/173m2
53.3
57.4
0.27
13
90
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
439
0.90
0.22
6.2
7.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
42
1.19
0.21
2.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
152.2
—
0
12
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.1
—
1.0
—
0
8
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
38
346
1.11
0.20
2.0
3.5
ng/l
304.4
232.9
0.27
32
324
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
52
1.16
0.19
1.7
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
82
778
1.07
0.18
4.6
4.2
estimate
0.0
0.0
0.00
33
216
(3022621) pH of Urine by Test strip
19
216
0.87
0.18
3.8
3.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
29
320
0.90
0.18
11.0
5.8
g/l
116.0
121.3
0.67
29
313
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
63
1.11
0.17
1.1
1.2
mmol/l
3.5
4.0
—
7
57
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
97
0.82
0.14
1.9
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
109
0.82
0.13
1.0
1.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
14
123
1.14
0.12
1.4
1.6
ug/l
0.5
2.5
—
9
107
(3016502) Oxygen saturation in Arterial blood
33
351
0.93
0.10
10.0
5.5
%
96.6
95.0
2.03
33
342
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
106
1.14
0.10
1.3
1.7
—
—
—
0
0
(4146454)
5
45
1.11
0.10
2.2
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
84
814
1.04
0.09
1.9
1.8
pmol/l
150769682.7
18196385.7
0.42
65
643
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
14.4
2.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
47
1.06
0.09
2.4
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
56
1.07
0.08
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
58
1.04
0.08
1.0
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
68
1.03
0.08
1.3
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
38
395
0.96
0.06
8.9
5.4
mmol/l
1.0
1.7
0.41
33
298
(36660697) Celiac disease serology panel - Serum
21
199
1.06
0.04
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
271
0.96
0.04
1.9
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
19
180
1.06
0.04
2.1
2.4
%
1.3
1.1
0.75
19
180
(3027801) Oxygen [Partial pressure] in Arterial blood
38
390
0.97
0.03
9.1
5.5
kpa
12.2
11.2
0.73
38
376
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
38
390
0.97
0.03
9.2
5.5
kpa
5.2
5.1
0.26
38
376
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
271
1.04
0.02
1.3
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
9
0.00
0.00
0.0
2.3
—
1.2
—
0
9
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.7
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
2.8
—
14.0
—
0
6
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
63
0.95
0.00
1.3
2.6
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
75.2
—
0
5
(3008898) HLA-B27 [Presence]
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_FACE_EXALLC – Melanoma in situ of other and unspecified parts of face
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).